Navigation Links
Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
Date:5/21/2013

BURLINGTON, Mass., May 21, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the effect of an emerging agent on key efficacy endpoints, including overall survival and time to disease progression, has the most influence over surveyed U.S. and European oncologists' prescribing decisions for advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast cancer. The two novel emerging therapies palbociclib (Pfizer's PD-0332991) and buparlisib (Novartis's BKM-120), both in combination with currently available hormonal therapies, are set to offer efficacy advantages over currently available agents used to treat this patient population.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO)

The Decision Base 2013 report entitled Breast Cancer (Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic): What Attributes will Distinguish Emerging Therapies in the Eyes of Oncologists and Payers?, finds that surveyed U.S. oncologists would prescribe palbociclib to 50 percent of their first-line advanced/metastatic HR-positive, HER2-negative breast cancer patients.

The report also finds that surveyed managed care organization (MCO) pharmacy directors are particularly receptive to novel therapies that offer an improvement in overall response rate (ORR) in this patient population. However, while several emerging therapies hold promise, Decision Resources does not expect any will match the clinical improvement in ORR over current therapies that surveyed U.S. payers indicated would be necessary for widespread inclusion on MCO formularies.

"This population represents a large and therefore potentially lucrative market segment for drug devel
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
2. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
3. Ludlow Research Issues Opinion on PMBS Based on Low Market Cap Valuation
4. For Osteoporosis and Osteopenia, Clinical Data and Thought Leaders Opinions Indicate that AMG-785/CDP-7851 and Odanacatib Have Advantages Over Alendronate
5. In Pretreated Advanced Renal Cell Carcinoma, Thought Leaders Opinions and Clinical Data Indicate that Tivopath Has Efficacy and Tolerability Advantages Over Currently Used Therapies
6. Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
7. Active Lifes BioDent Reference Point Indenter Validated in Study Published by Osteoporosis Medical Opinion Leaders
8. Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases
9. Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions
10. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
11. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015  Four financial ... a white paper released by Leaf Healthcare, ... for Healthcare Research & Quality (AHRQ), pressure ... $9.1-$11.6 billion annually . In addition to direct ... litigation, government penalties, and negatively impact hospital performance ...
(Date:9/3/2015)... SEATTLE , Sept. 3, 2015  Omeros Corporation ... filed patent infringement lawsuits against Par Pharmaceutical, Inc. and ... the U.S. District Court for the District of ... District Court for the District of Delaware ... Act for Par,s infringement of three Omeros patents, U.S. ...
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lnn7ss/investigation ... "Investigation Report on China,s Levothyroxine Market, 2010-2019" ... hormones (TH) have the greatest effect of promoting ... thyroid hormones mainly promote the growth and development ... growth hormone (GH) of pipuitary gland can,t work. ...
Breaking Medicine Technology:Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4Investigation Report on China's Levothyroxine Market, 2010-2019 2
... Dec. 9 The U.S. Food and Drug Administration ... workshop series--an opportunity for biotechnology companies, pharmaceutical firms, academics ... applications for orphan status designation, under the guidance of ... The first workshop is planned for Feb. 25-26, 2010, ...
... , BIRMINGHAM, Ala., Dec. 9 BioCryst Pharmaceuticals, Inc. ... M.D. has been elected to the Company,s Board of Directors. ... corporate executive and director, physician and professor of medicine. ... BioCryst,s Board of Directors," said Zola P. Horovitz, Ph.D., Chairman ...
Cached Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4
(Date:9/3/2015)... ... , ... Girl’s Night Out to benefit Core Compassion Project will be held ... in Monroe, North Carolina. The event food will be provided by Kate ... offers off-premise catering and event services from casual to elegant. They are also the ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... providers, has been retained to lead a national chief executive officer ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... Act (ACA) triggering cost increases for fully insured employer-sponsored health insurance plans, more ... employers (1,000+ employees), according to data released from the 2014 United Benefit Advisors ...
(Date:9/3/2015)... ... September 03, 2015 , ... ERT, ... collection, cloud analytics and workflow solutions today announced the complete faculty of ... 22-24, 2015. The esteemed faculty of worldwide pharmaceutical and industry experts will ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... AvePoint, ... that AvePoint Perimeter Service Pack (SP) 4 – AvePoint’s solution for facilitating ... named a “KMWorld 2015 Trend-Setting Product”. This is the fifth consecutive year ...
Breaking Medicine News(10 mins):Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4
... performed on the victim of a freak accident at a ... Andhra Pradesh on Thursday.// Welders and a motley crew of ... ,While trying to cross the road in the ... the road divider. One of the sharp-edged iron rods on ...
... Washington – Today, the nursing profession is sought after. The ... the noble profession,// lucrative. Many native nurses are making a ... it has become an exciting profession in recent years. ... exodus of nurses leaving their homeland to find work in ...
... preventable nosocomial infection or incident. ‘Safer Healthcare Now’ (SHN) in ... worked well to bring beneficial effects to patients in the ... working with six hundred health professionals in more than 180 ... response teams at the first sign of patient decline. 2. ...
... order enforced in New Delhi, the capital of India, has forbidden ... being the first of its kind in the world that publicly ... ,Doing two things at a time was never ... like driving. A city in which road accidents account for 1900 ...
... been buying an untried drug in the web hoping to find ... for dichlroacetate has been reported to decrease the size of tumors ... far. ,Understandably, terminally sick patients do not want to ... that around two hundred patients worldwide have bought this drug over ...
... food standards agency has come out with a good idea ... a view to encouraging// "portion size control" and improve the ... foods be sold in smaller packs. ,This move ... consumption of food stuff with high fat. Further, it would ...
Cached Medicine News:Health News:Campaign To Combat Medical Errors 2
... The Tangent Posterior Impacted Instrument Set ... Some of the advantages offered by the ... endplate preparation and the ability to reproduce ... heights to ensure proper vertebral body distraction. ...
Codman Hakim Programmable micro with Rickham Reservoir offers the ability to optimize the opening pressure of a shunt system before and after implantation. A shunted patient's condition will often ch...
... Osteopal V is a low viscosity bone ... in vertebroplasty. The bone cement is injected ... purposes. Osteopal V is used for the ... of zirconium dioxide is included in the ...
... to fuse multiple image sets in seconds, ... treatment planning and follow-up. ImageFusion aligns images ... features of different scan types. Radionics supports ... clinicians can capitalize on the unique strengths ...
Medicine Products: